NIH-funded research NIH-funded research

Investigating how proteins affect cellular processes related to diabetes

Official title: Processes mediated by polypeptides

Funded at University of Wisconsin-Madison · NIH-11014356 · Data updated 2026-11-12

This study is looking at how certain proteins work in the body and how they might be linked to adult-onset diabetes, with the hope of finding new ways to help manage the condition.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison
NIH-funded
Lab location1 site (Madison, United States)
Project startFebruary 1, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$578,813
NIH project number5R35GM151985-02
Project IDNIH-11014356 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with adult-onset diabetes or those experiencing related metabolic issues.

Less likely to help

Patients with conditions unrelated to protein signaling or those not affected by diabetes may not benefit from this research.

What this research studies

This research explores the role of proteins in cellular functions that are often disrupted in diseases like adult-onset diabetes. By using chemically synthesized polypeptides, the team aims to understand how these proteins interact with specific receptors in the body, particularly those involved in hormone signaling. The study focuses on G protein-coupled receptors (GPCRs) that are influenced by long polypeptide hormones, which are important for regulating blood sugar levels and other physiological processes. The findings could lead to new therapeutic strategies for managing diabetes and related conditions.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for diabetes and enhance our understanding of related metabolic disorders.

How similar studies have gone: Previous research has shown promise in understanding GPCRs and their role in diabetes treatment, indicating that this approach has potential for success.

Where this research is happening

  • University of Wisconsin-Madison
    Madison, United States
    Active

Researchers

  • Principal investigator: Gellman, Samuel H. — University of Wisconsin-Madison
  • Study coordinator: Gellman, Samuel H.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.